Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Replacement of fluid and electrolytes Age: Adult |
Dose: Intravenous solution – As 3% solution Note: Dosage depends on age, weight, clinical condition and laboratory determinations of the patient. Dose to be administered via a large vein, with care taken to prevent infiltration. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Severe symptomatic hyponatraemia |
Dose: Intravenous – 3 ml/kg Duration: over 20 minutes |
|
Indication: Severe symptomatic hyponatraemia |
Dose: Intravenous – 150 ml Duration: over 20 minutes |
Administration
- Used as prescribed by healthcare provider
- Follow specific mixing instructions
Side Effect
- Hypernatraemia
- thirst
- reduced salivation and lachrymation
- fever
- tachycardia
- hypertension
- headache
- dizziness
- restlessness
- irritability and weakness
- Intra-amniotic Injection of hypertonic solutions Disseminated intravascular coagulation
- renal necrosis
- cervical and uterine lesions
- pulmonary embolism
- pneumonia and death
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Lithium
|
May affect serum concentrations
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Conditions where sodium harmful
|
Risk of fluid overload
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.